Difference between revisions of "Part:BBa K3187001"
m |
|||
(10 intermediate revisions by 3 users not shown) | |||
Line 7: | Line 7: | ||
<div class="row"> | <div class="row"> | ||
<div class="col mx-2"> | <div class="col mx-2"> | ||
− | < | + | <h1>Profile</h1> |
− | <table style= | + | <table style="width:80%"> |
<tr> | <tr> | ||
<td><b>Name</b></td> | <td><b>Name</b></td> | ||
<td>Coat protein</td> | <td>Coat protein</td> | ||
</tr> | </tr> | ||
− | <tr> | + | <tr> |
<td><b>Base pairs</b></td> | <td><b>Base pairs</b></td> | ||
<td>1293</td> | <td>1293</td> | ||
Line 27: | Line 27: | ||
<tr> | <tr> | ||
<td><b>Parts</b></td> | <td><b>Parts</b></td> | ||
− | <td> Coat protein, T7 promoter, <i>lac</i>-operator, RBS, T7Te terminator, | + | <td> Coat protein, T7 promoter, <i>lac</i>-operator, RBS, T7Te terminator, rrnB T1 terminator, Short Linker 5AA, Strep-tagII </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 34: | Line 34: | ||
</tr> | </tr> | ||
</table> | </table> | ||
+ | |||
+ | <h1>Sequence and Features</h1> | ||
+ | </html> | ||
+ | |||
+ | <partinfo>BBa_K3187001 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | |||
+ | <html> | ||
− | + | <h1>Usage and Biology</h1> | |
− | < | + | <p>The P22 VLP originates from the temperate bacteriophage P22. Its natural host is <i>Salmonella typhimurium</i>. |
− | <p>This part encodes the coat protein (CP) <a href="https://parts.igem.org/Part:BBa_K3187017"target="_blank">(BBa_K3187017)</a> | + | Since it was isolated half a century ago it has been characterized thoroughly and has become a paradigm system for temperate phages. |
+ | To date, nearly everything is known about its lifecycle. Because of that and its specific properties it generates | ||
+ | an accessible VLP platform.<sup id="cite_ref-1" class="reference"> | ||
+ | <a href="#cite_note-1">[1]</a></sup><br> | ||
+ | </p> | ||
+ | <p>An assembled P22 VLP consists of 420 copies of coat protein (CP: <a href="https://parts.igem.org/Part:BBa_K3187017" target="_blank">BBa_K3187017</a>) and 100 to 300 copies of scaffold | ||
+ | protein (SP: <a href="https://parts.igem.org/Part:BBa_K3187021" target="_blank">BBa_K3187021</a>).<sup id="cite_ref-2" class="reference"> | ||
+ | <a href="#cite_note-2">[2]</a> | ||
+ | </sup><br> | ||
+ | The shell of the VLP is formed by the 46.6 kDa CP. The coat protein occurs in one configuration, which contains a globular | ||
+ | structure on the outer surface and an extended domain on the inner surface. Seven CPs arrange in asymmetric units, which form | ||
+ | the icosahedral structure of the VLP.<sup id="cite_ref-3" class="reference"> | ||
+ | <a href="#cite_note-3">[3]</a> | ||
+ | </sup><br> | ||
+ | The 18 kDa SP is required for an efficient assembly and naturally consists of 303 amino acids. It has been shown, that an | ||
+ | N‑terminal truncated SP of 163 amino acids retains its assembly efficiency. The 3D‑structure is composed of segmented helical | ||
+ | domains, with little or no globular core. In solution is a mixture of monomers and dimers present.<sup id="cite_ref-4" | ||
+ | class="reference"> | ||
+ | <a href="#cite_note-4">[4]</a> | ||
+ | </sup> | ||
+ | When purified CPs and SPs are mixed, they self‑assemble into VLPs. </p> | ||
+ | |||
+ | <p> The assembled P22 VLPs occur as a procapsid. If the VLP is heated up to 60 °C, the CP rearranges, forming | ||
+ | the expanded shell form (EX). This form has a diameter of about 58 nm and the volume is doubled compared to the one of | ||
+ | the procapsid. The expanded shell form changes into the whiffleball form (WB) when heated further up to 70 °C. The | ||
+ | whiffleball has 10 nm pores, while the procapsid or the expanded shell form only have 2 nm pores.<sup id="cite_ref-5" class="reference"> | ||
+ | <a href="#cite_note-5">[5]</a> | ||
+ | </sup> | ||
+ | Furthermore, the P22 VLP consists of SP and CP, but it also can assemble with only CPs. If it assembles without SP it can form | ||
+ | two sizes of capsids. The small capsid is built as a T = 4 icosahedral lattice with a diameter between 195 Å and 240 Å. The | ||
+ | larger capsid also has an icosahedral lattice, but it is formed as T = 7. T being the "triangulation number", a measure for | ||
+ | capsid size and complexity. Moreover, it is like the wild type VLP, which includes the SP. The diameter of the wild type VLP, is | ||
+ | between 260 Å and 306 Å. Each capsid consists of a 85 Å thick icosahedral shell made of CP.<sup id="cite_ref-6" class="reference"> | ||
+ | <a href="#cite_note-6">[6] </a> | ||
+ | </sup></p> | ||
+ | |||
+ | <p><br></p> | ||
+ | <p>This part encodes the coat protein (CP) <a href="https://parts.igem.org/Part:BBa_K3187017" target="_blank">(BBa_K3187017)</a> | ||
of the bacteriophage P22 capsid. Importantly, it must not be confused with coat | of the bacteriophage P22 capsid. Importantly, it must not be confused with coat | ||
proteins in membrane transport of eukaryotic cells. Coat protein is an umbrella term for many different proteins, which | proteins in membrane transport of eukaryotic cells. Coat protein is an umbrella term for many different proteins, which | ||
simplify | simplify | ||
the transfer of molecules between different compartments that are surrounded by a membrane. | the transfer of molecules between different compartments that are surrounded by a membrane. | ||
− | <sup id="cite_ref- | + | <sup id="cite_ref-7" class="reference"> |
− | <a href="#cite_note- | + | <a href="#cite_note-7">[7] </a> |
</sup> | </sup> | ||
<br> In the natural context of P22, its genetic information is included | <br> In the natural context of P22, its genetic information is included | ||
and protected by the capsid, before it is transferred into the host organism during infection. | and protected by the capsid, before it is transferred into the host organism during infection. | ||
− | <sup id="cite_ref- | + | <sup id="cite_ref-8" class="reference"> |
− | <a href="#cite_note- | + | <a href="#cite_note-8">[8] </a> |
</sup> | </sup> | ||
Bacteriophagic coat proteins have been used for many purposes, for example vaccines | Bacteriophagic coat proteins have been used for many purposes, for example vaccines | ||
− | <sup id="cite_ref- | + | <sup id="cite_ref-9" class="reference"> |
− | <a href="#cite_note- | + | <a href="#cite_note-9">[9] </a> |
</sup> | </sup> | ||
or drug delivery. | or drug delivery. | ||
− | <sup id="cite_ref- | + | <sup id="cite_ref-10" class="reference"> |
− | <a href="#cite_note- | + | <a href="#cite_note-10">[10] </a> |
</sup> | </sup> | ||
− | <br>The P22 coat protein <a href="https://parts.igem.org/Part:BBa_K3187001"target="_blank">(BBa_K3187001)</a> consists of 431 amino acids | + | <br>The P22 coat protein <a href="https://parts.igem.org/Part:BBa_K3187001" target="_blank">(BBa_K3187001)</a> consists of 431 amino acids |
− | and its molecular weight is 46.9 kDa. | + | and its molecular weight is 46.9 kDa. |
− | Because it is found in the structural components of viral proteins, it is an important part of Virus | + | Because it is found in the structural components of viral proteins, it is an important part of Virus‑like particles |
− | (VLP) as well. Together with the scaffold protein <a href="https://parts.igem.org/Part:BBa_K3187021"target="_blank">(BBa_K3187021)</a>, | + | (VLP) as well. Together with the scaffold protein <a href="https://parts.igem.org/Part:BBa_K3187021" target="_blank">(BBa_K3187021)</a>, |
the proteins assemble to a VLP | the proteins assemble to a VLP | ||
− | <sup id="cite_ref- | + | <sup id="cite_ref-11" class="reference"> |
− | <a href="#cite_note- | + | <a href="#cite_note-11">[11] </a> |
</sup> | </sup> | ||
and build the basis for our | and build the basis for our | ||
modular platform. | modular platform. | ||
</p> | </p> | ||
− | <p>The coat proteins <a href="https://parts.igem.org/Part:BBa_K3187001"target="_blank">(BBa_K3187001)</a> are heterologously expressed in | + | <p>The coat proteins <a href="https://parts.igem.org/Part:BBa_K3187001" target="_blank">(BBa_K3187001)</a> are heterologously expressed in |
− | <i>E. coli</i> BL21 (DE3). As backbone the pACYCT2 plasmid is used, | + | <i>E. coli</i> BL21 (DE3). As backbone the pACYCT2 plasmid is used, |
containing a | containing a | ||
− | <a href="https://parts.igem.org/Part:BBa_K3187029"target="_blank">T7 promoter, <i>lac</i>-operator and RBS (BBa_K3187029)</a>. | + | <a href="https://parts.igem.org/Part:BBa_K3187029" target="_blank">T7 promoter, <i>lac</i>-operator and RBS (BBa_K3187029)</a>. |
− | Moreover the part comprises a C-terminal Strep | + | Moreover the part comprises a C-terminal Strep‑tagII <a href="https://parts.igem.org/Part:BBa_K3187025" target="_blank">(BBa_K3187025)</a>, |
− | a Short Linker (5AA) <a href="https://parts.igem.org/Part:BBa_K3187030"target="_blank">(BBa_K3187030)</a> | + | a Short Linker (5AA) <a href="https://parts.igem.org/Part:BBa_K3187030" target="_blank">(BBa_K3187030)</a> |
− | and two terminators, T7Te terminator and | + | and two terminators, T7Te terminator and rrnB T1 terminator <a href="https://parts.igem.org/Part:BBa_K3187036" target="_blank">(BBa_K3187036)</a>. |
− | < | + | <h1>Methods</h1> |
− | < | + | <h2>Cloning</h2> |
<p>The sequence of the coat protein ordered from Integrated DNA Technologies (IDT) was inserted in the pACYCT2 backbone. | <p>The sequence of the coat protein ordered from Integrated DNA Technologies (IDT) was inserted in the pACYCT2 backbone. | ||
− | For this purpose, the <a href="https:// | + | For this purpose, the <a href="https://static.igem.org/mediawiki/2019/6/62/T--TU_Darmstadt--Methoden.pdf" target="_blank">Gibson asssembly</a> was used. |
The sequence was verified by sanger sequencing through Microsynth | The sequence was verified by sanger sequencing through Microsynth | ||
Seqlab. | Seqlab. | ||
</p> | </p> | ||
− | < | + | <h2>Purification</h2> |
− | <p> The heterologous expressed coat protein in <i>E. coli</i> was purified using a | + | <p> The heterologous expressed coat protein in <i>E. coli</i> was purified using a |
− | <a href="https:// | + | <a href="https://static.igem.org/mediawiki/2019/6/62/T--TU_Darmstadt--Methoden.pdf" target="_blank">GE Healthcare ÄKTA Pure machine</a> |
which is a machine for FPLC. | which is a machine for FPLC. | ||
</p> | </p> | ||
− | < | + | <h2>SDS-PAGE and western blot</h2> |
− | <p>To verify that the coat protein was heterologous produced, a SDS | + | <p>To verify that the coat protein was heterologous produced, a SDS‑PAGE followed by a |
− | <a href="https:// | + | <a href="https://static.igem.org/mediawiki/2019/6/62/T--TU_Darmstadt--Methoden.pdf" target="_blank">western blot</a> |
was performed. | was performed. | ||
+ | </p> | ||
+ | |||
+ | <h2>Assembly</h2> | ||
+ | <p>A VLP is assembled only with coat proteins without a tag and concentrated by <a href="https://static.igem.org/mediawiki/2019/6/62/T--TU_Darmstadt--Methoden.pdf" target="_blank">ultracentrifugation</a>. | ||
+ | To verify the assembly, the VLPs were detected by transmission electron microscopy | ||
+ | (<a href="https://static.igem.org/mediawiki/2019/6/62/T--TU_Darmstadt--Methoden.pdf" target="_blank">TEM</a>). | ||
+ | The hydrodynamic diameter was measured with dynamic light scattering analysis <a href="https://static.igem.org/mediawiki/2019/6/62/T--TU_Darmstadt--Methoden.pdf" target="_blank">(DLS)</a>. | ||
+ | </p> | ||
− | + | ||
− | < | + | <h1>Results</h1> |
− | < | + | <h2>Cloning and Expression</h2> |
<p>The ordered sequence from IDT was cloned into the pACYCT2 plasmid with Gibson assembly and heterologous expressed in | <p>The ordered sequence from IDT was cloned into the pACYCT2 plasmid with Gibson assembly and heterologous expressed in | ||
− | <i>E. coli</i>. The accuracy of cloning was controlled via sanger sequencing (Microsynth Seqlab ) and the production | + | <i>E. coli</i>. The accuracy of cloning was controlled via sanger sequencing (Microsynth Seqlab) and the production |
− | was observed using an SDS | + | was observed using an SDS‑PAGE and western blot. |
</p> | </p> | ||
− | <div | + | <div> |
− | <a href=" | + | <a href="https://2019.igem.org/wiki/images/9/9c/T--TU_Darmstadt--Western_blot_CP-LPETGG_CP.jpeg" target="_blank"> |
<img class="img-fluid center" src="https://2019.igem.org/wiki/images/9/9c/T--TU_Darmstadt--Western_blot_CP-LPETGG_CP.jpeg" style="max-width:60%" /> | <img class="img-fluid center" src="https://2019.igem.org/wiki/images/9/9c/T--TU_Darmstadt--Western_blot_CP-LPETGG_CP.jpeg" style="max-width:60%" /> | ||
</a> | </a> | ||
Line 112: | Line 165: | ||
<p> | <p> | ||
<b>Figure 1:</b> | <b>Figure 1:</b> | ||
− | + | western blot of all produced and purified proteins. | |
</p> | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
− | <p>Fig. 1 shows that the CPs were detected with Strep | + | <p><b>Fig. 1</b> shows that the CPs were detected with Strep‑Tactin‑HRP. |
− | The | + | The western blot shows a band corresponding to the size of approximately 46.9 kDa. |
So, the successful production was proven. | So, the successful production was proven. | ||
− | </p> | + | </p> |
+ | |||
+ | <p>The diameter of VLPs consisting of different protein combinations was measured with dynamic light scattering (DLS) analysis.</p> | ||
+ | <div> | ||
+ | <a href="https://2019.igem.org/wiki/images/6/68/T--TU_DARMSTADT--DLS_ohne_Mod.png" target="_blank"> | ||
+ | <img class="img-fluid center" src="https://2019.igem.org/wiki/images/6/68/T--TU_DARMSTADT--DLS_ohne_Mod.png" style="max-width:70%" /> | ||
+ | </a> | ||
+ | <div class="caption"> | ||
+ | <p> | ||
+ | <b>Figure 2:</b> | ||
+ | Diagram of DLS measurment of VLPs . | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <p> | ||
+ | We showed by dynamic | ||
+ | light scattering (DLS) analysis (<b>Fig. 2</b>) that capsids containing only CP are smaller than P22‑VLPs containing both CP and SP. This was | ||
+ | also confirmed by measuring VLPs and CP‑only capsids in TEM images using ImageJ. Capsids which are only composed of CP measured | ||
+ | average diameter of 53 nm ± 4.3 nm are significantly smaller than VLPs out of SP and CP measured average diameter of 57 nm ± 3 nm | ||
+ | (n=20; p < 0.005). What also became clear is that the presence of the LPETGG tag does not affect the size of the assembled CP‑only | ||
+ | capsid. | ||
+ | </p> | ||
+ | |||
Line 126: | Line 201: | ||
<h2>References</h2> | <h2>References</h2> | ||
<ol class="references"> | <ol class="references"> | ||
− | + | <li id="cite_note-1"> | |
+ | <span class="mw-cite-backlink"> | ||
+ | <a href="#cite_ref-1">↑</a> | ||
+ | </span> | ||
+ | <span class="reference-text"> | ||
+ | Sherwood Casjens and Peter Weigele, DNA Packaging by Bacteriophage P22, Viral Genome Packaging Machines: Genetics, | ||
+ | Structure, and Mechanism, 2005, pp 80- 88 | ||
+ | <a rel="nofollow" class="external autonumber" href="https://link.springer.com/chapter/10.1007/0-387-28521-0_5">[1] </a> | ||
+ | </span> | ||
+ | </li> | ||
+ | |||
+ | <li id="cite_note-2"> | ||
+ | <span class="mw-cite-backlink"> | ||
+ | <a href="#cite_ref-2">↑</a> | ||
+ | </span> | ||
+ | <span class="reference-text"> | ||
+ | Dustin Patterson, Benjamin LaFrance, Trevor Douglas, Rescuing recombinant proteins by sequestration into the P22 VLP, | ||
+ | Chemical Communications, 2013, 49: 10412-10414 | ||
+ | <a rel="nofollow" class="external autonumber" href="https://pubs.rsc.org/en/content/articlelanding/2013/cc/c3cc46517a#!divAbstract">[2] </a> | ||
+ | </span> | ||
+ | </li> | ||
+ | |||
+ | <li id="cite_note-3"> | ||
+ | <span class="mw-cite-backlink"> | ||
+ | <a href="#cite_ref-3">↑</a> | ||
+ | </span> | ||
+ | <span class="reference-text"> | ||
+ | Wen Jiang, Zongli Li, Zhixian Zhang, Matthew Baker, Peter Prevelige Jr., and Wah Chiu, Coat protein fold and | ||
+ | maturation transition of bacteriophage P22 seen at subnanometer resolutions,Nature Structural Biology, 2003, 10: 131-135 | ||
+ | <a rel="nofollow" class="external autonumber" href="https://www.nature.com/articles/nsb891">[3] </a> | ||
+ | </span> | ||
+ | </li> | ||
+ | |||
+ | <li id="cite_note-4"> | ||
+ | <span class="mw-cite-backlink"> | ||
+ | <a href="#cite_ref-4">↑</a> | ||
+ | </span> | ||
+ | <span class="reference-text"> | ||
+ | Matthew Parker, Sherwood Casjens, Peter Prevelige Jr., Functional domains of bacteriophage P22 scaffolding protein, | ||
+ | Journal of Molecular Biology, 1998, Volume 281: 69-79 | ||
+ | <a rel="nofollow" class="external autonumber" href="https://www.sciencedirect.com/science/article/pii/S0022283698919179">[4] </a> | ||
+ | </span> | ||
+ | </li> | ||
+ | |||
+ | <li id="cite_note-5"> | ||
+ | <span class="mw-cite-backlink"> | ||
+ | <a href="#cite_ref-5">↑</a> | ||
+ | </span> | ||
+ | <span class="reference-text"> | ||
+ | Dustin Patterson, Peter Prevelige, Trevor Douglas, Nanoreactors by Programmed Enzyme Encapsulation Inside the Capsid | ||
+ | of the Bacteriophage P22, American Chemical Society, 2012, 6: 5000-5009 | ||
+ | <a rel="nofollow" class="external autonumber" href="https://pubs.acs.org/doi/pdf/10.1021/nn300545z">[5] </a> | ||
+ | </span> | ||
+ | </li> | ||
+ | |||
+ | <li id="cite_note-6"> | ||
+ | <span class="mw-cite-backlink"> | ||
+ | <a href="#cite_ref-6">↑</a> | ||
+ | </span> | ||
+ | <span class="reference-text"> | ||
+ | P A Thuman-Commike, B Greene, J A Malinski, J King, and W Chiu, Role of the scaffolding protein in P22 procapsid size | ||
+ | determination suggested by T = 4 and T = 7 procapsid structures.,Biophysical Journal, 1998, 74: 559-568 | ||
+ | <a rel="nofollow" class="external autonumber" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1299408/">[6] </a> | ||
+ | </span> | ||
+ | </li> | ||
+ | <li id="cite_note-7"> | ||
<span class="mw-cite-backlink"> | <span class="mw-cite-backlink"> | ||
− | <a href="#cite_ref- | + | <a href="#cite_ref-7">↑</a> |
</span> | </span> | ||
<span class="reference-text"> | <span class="reference-text"> | ||
Juan S. Bonifacino, Jennifer Lippincott-Schwartz, Coat proteins: shaping membranetransport, | Juan S. Bonifacino, Jennifer Lippincott-Schwartz, Coat proteins: shaping membranetransport, | ||
NATURE REVIEWS MOLECULAR CELLBIOLOGY, May 2013, 4, 409-414 | NATURE REVIEWS MOLECULAR CELLBIOLOGY, May 2013, 4, 409-414 | ||
− | <a rel="nofollow" class="external autonumber" href="https://www.nature.com/articles/nrm1099">[ | + | <a rel="nofollow" class="external autonumber" href="https://www.nature.com/articles/nrm1099">[7] </a> |
</span> | </span> | ||
</li> | </li> | ||
− | <li id="cite_note- | + | <li id="cite_note-8"> |
<span class="mw-cite-backlink"> | <span class="mw-cite-backlink"> | ||
− | <a href="#cite_ref- | + | <a href="#cite_ref-8">↑</a> |
</span> | </span> | ||
<span class="reference-text"> | <span class="reference-text"> | ||
Line 144: | Line 284: | ||
Genetics, Structure, and Mechanism, 2005, 80- 88 | Genetics, Structure, and Mechanism, 2005, 80- 88 | ||
<a rel="nofollow" class="external autonumber" | <a rel="nofollow" class="external autonumber" | ||
− | href="https://link.springer.com/chapter/10.1007/0-387-28521-0_5">[ | + | href="https://link.springer.com/chapter/10.1007/0-387-28521-0_5">[8] </a> |
</span> | </span> | ||
</li> | </li> | ||
Line 150: | Line 290: | ||
− | <li id="cite_note- | + | <li id="cite_note-9"> |
<span class="mw-cite-backlink"> | <span class="mw-cite-backlink"> | ||
− | <a href="#cite_ref- | + | <a href="#cite_ref-9">↑</a> |
</span> | </span> | ||
<span class="reference-text"> | <span class="reference-text"> | ||
Roldão A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM, Virus-like particles in vaccine development., | Roldão A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM, Virus-like particles in vaccine development., | ||
Expert Rev Vaccines, 2010, 9: 1149-1176 | Expert Rev Vaccines, 2010, 9: 1149-1176 | ||
− | <a rel="nofollow" class="external autonumber" href="https://www.ncbi.nlm.nih.gov/pubmed/20923267" target="_blank">[ | + | <a rel="nofollow" class="external autonumber" href="https://www.ncbi.nlm.nih.gov/pubmed/20923267" target="_blank">[9] </a> |
</span> | </span> | ||
</li> | </li> | ||
− | <li id="cite_note- | + | <li id="cite_note-10"> |
<span class="mw-cite-backlink"> | <span class="mw-cite-backlink"> | ||
− | <a href="#cite_ref- | + | <a href="#cite_ref-10">↑</a> |
</span> | </span> | ||
<span class="reference-text"> | <span class="reference-text"> | ||
Rohovie, Marcus J., Maya Nagasawa, and James R. Swartz. "Virus‐like particles: Next‐generation nanoparticles | Rohovie, Marcus J., Maya Nagasawa, and James R. Swartz. "Virus‐like particles: Next‐generation nanoparticles | ||
− | for targeted therapeutic delivery." Bioengineering & translational medicine 2.1 (2017): 43-57 | + | for targeted therapeutic delivery." Bioengineering & translational medicine 2.1 (2017): 43-57 |
− | <a rel="nofollow" class="external autonumber" href="https://aiche.onlinelibrary.wiley.com/doi/full/10.1002/btm2.10049">[ | + | <a rel="nofollow" class="external autonumber" href="https://aiche.onlinelibrary.wiley.com/doi/full/10.1002/btm2.10049">[10] </a> |
</span> | </span> | ||
</li> | </li> | ||
− | <li id="cite_note- | + | <li id="cite_note-11"> |
<span class="mw-cite-backlink"> | <span class="mw-cite-backlink"> | ||
− | <a href="#cite_ref- | + | <a href="#cite_ref-11">↑</a> |
</span> | </span> | ||
<span class="reference-text"> | <span class="reference-text"> | ||
Line 179: | Line 319: | ||
diffraction | diffraction | ||
from heads, proheads and related structures J. Mol. Biol. 1976, 104, 387. | from heads, proheads and related structures J. Mol. Biol. 1976, 104, 387. | ||
− | <a rel="nofollow" class="external autonumber" href="https://www.sciencedirect.com/science/article/pii/0022283676902783?via%3Dihub">[ | + | <a rel="nofollow" class="external autonumber" href="https://www.sciencedirect.com/science/article/pii/0022283676902783?via%3Dihub">[11] </a> |
</span> | </span> | ||
</li> | </li> | ||
Line 187: | Line 327: | ||
</div> | </div> | ||
</html> | </html> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | |||
− | |||
− | |||
− | |||
Latest revision as of 23:01, 21 October 2019
P22 Bacteriophage Coat Protein expression cassette
Profile
Name | Coat protein |
Base pairs | 1293 |
Molecular weight | 46.9 kDa |
Origin | Bacteriophage P22 |
Parts | Coat protein, T7 promoter, lac-operator, RBS, T7Te terminator, rrnB T1 terminator, Short Linker 5AA, Strep-tagII |
Properties | Assembly with scaffold protein to a Virus-like particle |
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 1458
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 1504
Usage and Biology
The P22 VLP originates from the temperate bacteriophage P22. Its natural host is Salmonella typhimurium.
Since it was isolated half a century ago it has been characterized thoroughly and has become a paradigm system for temperate phages.
To date, nearly everything is known about its lifecycle. Because of that and its specific properties it generates
an accessible VLP platform.
[1]
An assembled P22 VLP consists of 420 copies of coat protein (CP: BBa_K3187017) and 100 to 300 copies of scaffold
protein (SP: BBa_K3187021).
[2]
The shell of the VLP is formed by the 46.6 kDa CP. The coat protein occurs in one configuration, which contains a globular
structure on the outer surface and an extended domain on the inner surface. Seven CPs arrange in asymmetric units, which form
the icosahedral structure of the VLP.
[3]
The 18 kDa SP is required for an efficient assembly and naturally consists of 303 amino acids. It has been shown, that an
N‑terminal truncated SP of 163 amino acids retains its assembly efficiency. The 3D‑structure is composed of segmented helical
domains, with little or no globular core. In solution is a mixture of monomers and dimers present.
[4]
When purified CPs and SPs are mixed, they self‑assemble into VLPs.
The assembled P22 VLPs occur as a procapsid. If the VLP is heated up to 60 °C, the CP rearranges, forming the expanded shell form (EX). This form has a diameter of about 58 nm and the volume is doubled compared to the one of the procapsid. The expanded shell form changes into the whiffleball form (WB) when heated further up to 70 °C. The whiffleball has 10 nm pores, while the procapsid or the expanded shell form only have 2 nm pores. [5] Furthermore, the P22 VLP consists of SP and CP, but it also can assemble with only CPs. If it assembles without SP it can form two sizes of capsids. The small capsid is built as a T = 4 icosahedral lattice with a diameter between 195 Å and 240 Å. The larger capsid also has an icosahedral lattice, but it is formed as T = 7. T being the "triangulation number", a measure for capsid size and complexity. Moreover, it is like the wild type VLP, which includes the SP. The diameter of the wild type VLP, is between 260 Å and 306 Å. Each capsid consists of a 85 Å thick icosahedral shell made of CP. [6]
This part encodes the coat protein (CP) (BBa_K3187017)
of the bacteriophage P22 capsid. Importantly, it must not be confused with coat
proteins in membrane transport of eukaryotic cells. Coat protein is an umbrella term for many different proteins, which
simplify
the transfer of molecules between different compartments that are surrounded by a membrane.
[7]
In the natural context of P22, its genetic information is included
and protected by the capsid, before it is transferred into the host organism during infection.
[8]
Bacteriophagic coat proteins have been used for many purposes, for example vaccines
[9]
or drug delivery.
[10]
The P22 coat protein (BBa_K3187001) consists of 431 amino acids
and its molecular weight is 46.9 kDa.
Because it is found in the structural components of viral proteins, it is an important part of Virus‑like particles
(VLP) as well. Together with the scaffold protein (BBa_K3187021),
the proteins assemble to a VLP
[11]
and build the basis for our
modular platform.
The coat proteins (BBa_K3187001) are heterologously expressed in E. coli BL21 (DE3). As backbone the pACYCT2 plasmid is used, containing a T7 promoter, lac-operator and RBS (BBa_K3187029). Moreover the part comprises a C-terminal Strep‑tagII (BBa_K3187025), a Short Linker (5AA) (BBa_K3187030) and two terminators, T7Te terminator and rrnB T1 terminator (BBa_K3187036).
Methods
Cloning
The sequence of the coat protein ordered from Integrated DNA Technologies (IDT) was inserted in the pACYCT2 backbone. For this purpose, the Gibson asssembly was used. The sequence was verified by sanger sequencing through Microsynth Seqlab.
Purification
The heterologous expressed coat protein in E. coli was purified using a GE Healthcare ÄKTA Pure machine which is a machine for FPLC.
SDS-PAGE and western blot
To verify that the coat protein was heterologous produced, a SDS‑PAGE followed by a western blot was performed.
Assembly
A VLP is assembled only with coat proteins without a tag and concentrated by ultracentrifugation. To verify the assembly, the VLPs were detected by transmission electron microscopy (TEM). The hydrodynamic diameter was measured with dynamic light scattering analysis (DLS).
Results
Cloning and Expression
The ordered sequence from IDT was cloned into the pACYCT2 plasmid with Gibson assembly and heterologous expressed in E. coli. The accuracy of cloning was controlled via sanger sequencing (Microsynth Seqlab) and the production was observed using an SDS‑PAGE and western blot.
Fig. 1 shows that the CPs were detected with Strep‑Tactin‑HRP. The western blot shows a band corresponding to the size of approximately 46.9 kDa. So, the successful production was proven.
The diameter of VLPs consisting of different protein combinations was measured with dynamic light scattering (DLS) analysis.
We showed by dynamic light scattering (DLS) analysis (Fig. 2) that capsids containing only CP are smaller than P22‑VLPs containing both CP and SP. This was also confirmed by measuring VLPs and CP‑only capsids in TEM images using ImageJ. Capsids which are only composed of CP measured average diameter of 53 nm ± 4.3 nm are significantly smaller than VLPs out of SP and CP measured average diameter of 57 nm ± 3 nm (n=20; p < 0.005). What also became clear is that the presence of the LPETGG tag does not affect the size of the assembled CP‑only capsid.
References
- ↑ Sherwood Casjens and Peter Weigele, DNA Packaging by Bacteriophage P22, Viral Genome Packaging Machines: Genetics, Structure, and Mechanism, 2005, pp 80- 88 [1]
- ↑ Dustin Patterson, Benjamin LaFrance, Trevor Douglas, Rescuing recombinant proteins by sequestration into the P22 VLP, Chemical Communications, 2013, 49: 10412-10414 [2]
- ↑ Wen Jiang, Zongli Li, Zhixian Zhang, Matthew Baker, Peter Prevelige Jr., and Wah Chiu, Coat protein fold and maturation transition of bacteriophage P22 seen at subnanometer resolutions,Nature Structural Biology, 2003, 10: 131-135 [3]
- ↑ Matthew Parker, Sherwood Casjens, Peter Prevelige Jr., Functional domains of bacteriophage P22 scaffolding protein, Journal of Molecular Biology, 1998, Volume 281: 69-79 [4]
- ↑ Dustin Patterson, Peter Prevelige, Trevor Douglas, Nanoreactors by Programmed Enzyme Encapsulation Inside the Capsid of the Bacteriophage P22, American Chemical Society, 2012, 6: 5000-5009 [5]
- ↑ P A Thuman-Commike, B Greene, J A Malinski, J King, and W Chiu, Role of the scaffolding protein in P22 procapsid size determination suggested by T = 4 and T = 7 procapsid structures.,Biophysical Journal, 1998, 74: 559-568 [6]
- ↑ Juan S. Bonifacino, Jennifer Lippincott-Schwartz, Coat proteins: shaping membranetransport, NATURE REVIEWS MOLECULAR CELLBIOLOGY, May 2013, 4, 409-414 [7]
- ↑ Sherwood Casjens and Peter Weigele, DNA Packaging by Bacteriophage P22, Viral Genome Packaging Machines: Genetics, Structure, and Mechanism, 2005, 80- 88 [8]
- ↑ Roldão A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM, Virus-like particles in vaccine development., Expert Rev Vaccines, 2010, 9: 1149-1176 [9]
- ↑ Rohovie, Marcus J., Maya Nagasawa, and James R. Swartz. "Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery." Bioengineering & translational medicine 2.1 (2017): 43-57 [10]
- ↑ W. Earnshaw, S. Casjens, S. C. Harrison, Assembly of the head of bacteriophage P22: X-ray diffraction from heads, proheads and related structures J. Mol. Biol. 1976, 104, 387. [11]